" class="no-js "lang="en-US"> COVID-19 Archives - Page 27 of 27 - Medtech Alert
Sunday, September 28, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Sort by:

Date

Top Post

FDA statement on following the authorized dosing schedules for COVID-19 vaccines | Pharmtech Focus

FDA statement on following the authorized dosing schedules for COVID-19 vaccines

Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 […]

Read more

COVID-19

 Moderna announces FDA Authorization of Moderna COVID-19 vaccine in U.S. | Pharmtech Focus

Moderna announces FDA Authorization of Moderna COVID-19 vaccine in U.S.

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that […]

COVID-19

 Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19 | Pharmtech Focus

Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19

Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in […]

COVID-19

 Surging Nanotech Investments Boost Global Healthcare and Pandemic Protection | Pharmtech Focus

Surging Nanotech Investments Boost Global Healthcare and Pandemic Protection

COVID-19’s outbreak has coincided with investments flooding into nanotech-based healthcare companies, according to Pitchbook‘s latest […]

COVID-19

 Cyber Tech Company Develops Corona Virus Digital Health Passport with VCode® | Pharmtech Focus

Cyber Tech Company Develops Corona Virus Digital Health Passport with VCode®

VST Enterprises Ltd (VSTE) the British cyber security company founded by tech entrepreneur Louis-James Davis […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more